These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 37515406)
21. α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation. Falke M; Victor J; Wördehoff MM; Peduzzo A; Zhang T; Schröder GF; Buell AK; Hoyer W; Etzkorn M Chem Phys Lipids; 2019 May; 220():57-65. PubMed ID: 30826264 [TBL] [Abstract][Full Text] [Related]
22. Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation. Flagmeier P; Meisl G; Vendruscolo M; Knowles TP; Dobson CM; Buell AK; Galvagnion C Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10328-33. PubMed ID: 27573854 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation. Caillon L; Lequin O; Khemtémourian L Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907 [TBL] [Abstract][Full Text] [Related]
24. In silico investigation of the structural stability as the origin of the pathogenicity of Yoon J; Lee M; Park Y; Lee K; Shin S J Biomol Struct Dyn; 2023; 41(23):14103-14115. PubMed ID: 37036430 [No Abstract] [Full Text] [Related]
25. The H50Q mutation induces a 10-fold decrease in the solubility of α-synuclein. Porcari R; Proukakis C; Waudby CA; Bolognesi B; Mangione PP; Paton JF; Mullin S; Cabrita LD; Penco A; Relini A; Verona G; Vendruscolo M; Stoppini M; Tartaglia GG; Camilloni C; Christodoulou J; Schapira AH; Bellotti V J Biol Chem; 2015 Jan; 290(4):2395-404. PubMed ID: 25505181 [TBL] [Abstract][Full Text] [Related]
26. N-Terminal Acetylation of α-Synuclein Slows down Its Aggregation Process and Alters the Morphology of the Resulting Aggregates. Bell R; Thrush RJ; Castellana-Cruz M; Oeller M; Staats R; Nene A; Flagmeier P; Xu CK; Satapathy S; Galvagnion C; Wilson MR; Dobson CM; Kumita JR; Vendruscolo M Biochemistry; 2022 Sep; 61(17):1743-1756. PubMed ID: 35944093 [TBL] [Abstract][Full Text] [Related]
27. Disulfide-Mediated Elongation of Amyloid Fibrils of α-Synuclein For Use in Producing Self-Healing Hydrogel and Dye-Absorbing Aerogel. Ha Y; Kwon Y; Nam EJ; Park H; Paik SR Acta Biomater; 2022 Jun; 145():52-61. PubMed ID: 35421616 [TBL] [Abstract][Full Text] [Related]
28. Kinetic control in amyloid polymorphism: Different agitation and solution conditions promote distinct amyloid polymorphs of alpha-synuclein. Devi S; Garg DK; Bhat R Biochim Biophys Acta Proteins Proteom; 2023 Jul; 1871(4):140917. PubMed ID: 37061153 [TBL] [Abstract][Full Text] [Related]
29. Detection of amyloid fibrils in Parkinson's disease using plasmonic chirality. Kumar J; Eraña H; López-Martínez E; Claes N; Martín VF; Solís DM; Bals S; Cortajarena AL; Castilla J; Liz-Marzán LM Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3225-3230. PubMed ID: 29531058 [TBL] [Abstract][Full Text] [Related]
30. Mechanistic insight into the relationship between N-terminal acetylation of α-synuclein and fibril formation rates by NMR and fluorescence. Kang L; Janowska MK; Moriarty GM; Baum J PLoS One; 2013; 8(9):e75018. PubMed ID: 24058647 [TBL] [Abstract][Full Text] [Related]
31. The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains. Peña-Díaz S; Pujols J; Vasili E; Pinheiro F; Santos J; Manglano-Artuñedo Z; Outeiro TF; Ventura S J Biol Chem; 2022 May; 298(5):101902. PubMed ID: 35390347 [TBL] [Abstract][Full Text] [Related]
32. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations. Lewis KA; Yaeger A; DeMartino GN; Thomas PJ J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295 [TBL] [Abstract][Full Text] [Related]
33. S100A9 Alters the Pathway of Alpha-Synuclein Amyloid Aggregation. Toleikis Z; Ziaunys M; Baranauskiene L; Petrauskas V; Jaudzems K; Smirnovas V Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360737 [TBL] [Abstract][Full Text] [Related]
34. Protein/lipid coaggregates are formed during α-synuclein-induced disruption of lipid bilayers. van Maarschalkerweerd A; Vetri V; Langkilde AE; Foderà V; Vestergaard B Biomacromolecules; 2014 Oct; 15(10):3643-54. PubMed ID: 25210839 [TBL] [Abstract][Full Text] [Related]
35. Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein. Tuttle MD; Comellas G; Nieuwkoop AJ; Covell DJ; Berthold DA; Kloepper KD; Courtney JM; Kim JK; Barclay AM; Kendall A; Wan W; Stubbs G; Schwieters CD; Lee VM; George JM; Rienstra CM Nat Struct Mol Biol; 2016 May; 23(5):409-15. PubMed ID: 27018801 [TBL] [Abstract][Full Text] [Related]
36. The 3D structure of lipidic fibrils of α-synuclein. Frieg B; Antonschmidt L; Dienemann C; Geraets JA; Najbauer EE; Matthes D; de Groot BL; Andreas LB; Becker S; Griesinger C; Schröder GF Nat Commun; 2022 Nov; 13(1):6810. PubMed ID: 36357403 [TBL] [Abstract][Full Text] [Related]
38. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease. Galvagnion C J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142 [TBL] [Abstract][Full Text] [Related]